The susceptibility of dermatophytes to photodynamic treatment with special focus on Trichophyton rubrum

Photochemistry and Photobiology

Volumn 87, Issue 1, 2011, Pages 2-13

  Smijs, Threes G M ^a,b   Pavel, Stan ^c  

^a OPEN UNIVERSITY OF THE NETHERLANDS   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

DRUG EFFECT; HUMAN; PHOTOCHEMOTHERAPY; REVIEW; TINEA; TRICHOPHYTON;

ANTIFUNGAL AGENTS; HUMANS; PHOTOCHEMOTHERAPY; TINEA; TRICHOPHYTON;

ARTHRODERMATACEAE; BACTERIA (MICROORGANISMS); FUNGI; TRICHOPHYTON RUBRUM;

EID: 78650666754     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2010.00848.x     Document Type: Review

References (112)

1. Henderson, B. W., and, T. J. Dougherty, (1992) How does photodynamic therapy work? Photochem. Photobiol. 55, 145-157.
2. Marcus, S. L., and, W. R. McIntyre, (2002) Photodynamic therapy systems and applications. Expert. Opin. Emerg. Drugs 7, 321-334.
3. Dougherty, T. J., (2002) An update on photodynamic therapy applications. J. Clin. Laser Med. Surg. 20, 3-7.
4. Nestor, M. S., M. H. Gold, A. N. Kauvar, A. F. Taub, R. G. Geronemus, E. C. Ritvo, M. P. Goldman, D. J. Gilbert, D. F. Richey, T. S. Alster, R. R. Anderson, D. E. Bank, A. Carruthers, J. Carruthers, D. J. Goldberg, C. W. Hanke, N. J. Lowe, D. M. Pariser, D. S. Rigel, P. Robins, J. M. Spencer, and, B. D. Zelickson, (2006) The use of photodynamic therapy in dermatology: Results of a consensus conference. J. Drugs Dermatol. 5, 140-154.
5. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, and, Q. Peng, (1998) Photodynamic therapy. J. Natl Cancer Inst. 90, 889-905. (Pubitemid 28304157)
6. Lui, H., and, R. R. Anderson, (1993) Photodynamic therapy in dermatology: Recent developments. Dermatol. Clin. 11, 1-13.
7. Babilas, P., S. Schreml, M. Landthaler, and, R. M. Szeimies, (2010) Photodynamic therapy in dermatology: State-of-the-art. Photodermatol. Photoimmunol. Photomed. 26, 118-132.
8. Soergel, P., and, P. Hillemanns, (2010) Photodynamic therapy for intraepithelial neoplasia of the lower genital tract. Photodiagnosis Photodyn. Ther. 7, 10-14.
9. Nucci, V., D. Torchia, and, P. Cappugi, (2010) Treatment of anogenital condylomata acuminata with topical photodynamic therapy: Report of 14 cases and review. Int. J. Infect. Dis. 14, Suppl. 3, e280-282.
10. Boehncke, W. H., T. Elshorst-Schmidt, and, R. Kaufmann, (2000) Systemic photodynamic therapy is a safe and effective treatment for psoriasis. Arch. Dermatol. 136, 271-272.
11. Kalka, K., H. Merk, and, H. Mukhtar, (2000) Photodynamic therapy in dermatology. J. Am. Acad. Dermatol. 42, 389-413.
12. Taub, A. F., (2007) Photodynamic therapy: Other uses. Dermatol. Clin. 25, 101-109.
13. Fuchs, B. B., G. P. Tegos, M. R. Hamblin, and, E. Mylonakis, (2007) Susceptibility of Cryptococcus neoformans to photodynamic inactivation is associated with cell wall integrity. Antimicrob. Agents Chemother. 51, 2929-2936.
14. Mang, T. S., L. Mikulski, and, R. E. Hall, (2010) Photodynamic inactivation of normal and antifungal resistant Candida species. Photodiagnosis Photodyn. Ther. 7, 98-105.
15. Propst, C., and, L. Lubin, (1978) In vitro and in vivo photosensitized inactivation of dermatophyte fungi by heterotricyclic dyes. Infect. Immun. 20, 136-141.
16. Huang, L., Y. Y. Huang, P. Mroz, G. P. Tegos, T. Zhiyentayev, S. K. Sharma, Z. Lu, T. Balasubramian, M. Krayer, C. Ruzie, E. Yang, H. L. Kee, C. Kirmaier, J. R. Diers, D. F. Bocian, D. Holten, J. S. Lindsey, and, M. R. Hamblin, (2010) Stable synthetic cationic bacteriochlorins as selective antimicrobial photosensitizers. Antimicrob. Agents Chemother. 54 (9), 3834-3841.
17. Qiao, J., R. Li, Y. Ding, and, H. Fang, (2010) Photodynamic therapy in the treatment of superficial mycoses: An evidence-based evaluation. Mycopathologia 170 (5), 339-343.
18. Calzavara-Pinton, P. G., M. Venturini, R. Capezzera, R. Sala, and, C. Zane, (2004) Photodynamic therapy of interdigital mycoses of the feet with topical application of 5-aminolevulinic acid. Photodermatol. Photoimmunol. Photomed. 20, 144-147.
19. Calzavara-Pinton, P. G., M. Venturini, and, R. Sala, (2005) A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. J. Photochem. Photobiol. B 78, 1-6.
20. Kamp, H., H. J. Tietz, M. Lutz, H. Piazena, P. Sowyrda, J. Lademann, and, U. Blume-Peytavi, (2005) Antifungal effect of 5-aminolevulinic acid PDT in Trichophyton rubrum. Mycoses 48, 101-107.
21. Calzavara-Pinton, P., M. Venturini, and, R. Sala, (2007) Photodynamic therapy: Update 2006 Part 1: Photochemistry and photobiology. J. Eur. Acad. Dermatol. Venereol. 21, 293-302.
22. Donnelly, R. F., P. A. McCarron, M. M. Tunney, and, W. A. David, (2007) Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characterisation of a mucoadhesive patch containing toluidine blue O. J. Photochem. Photobiol. B 86, 59-69.
23. Fritsche, T. R., H. S. Sader, and, R. N. Jones, (2007) Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: Report from the SENTRY antimicrobial surveillance program (1999-2004). Diagn. Microbiol. Infect. Dis. 58, 19-26.
24. Wise, R., T. Hart, O. Cars, M. Streulens, R. Helmuth, P. Huovinen, and, M. Sprenger, (1998) Antimicrobial resistance. Is a major threat to public health. BMJ 317, 609-610.
25. Maisch, T., R. M. Szeimies, G. Jori, and, C. Abels, (2004) Antibacterial photodynamic therapy in dermatology. Photochem. Photobiol. Sci. 3, 907-917.
26. Boyce, J. M., (1995) Strategies for controlling methicillin-resistant Staphylococcus aureus in hospitals. J. Chemother. 7 (Suppl. 3), 81-85.
27. Manzano-Gayosso, P., L. J. Mendez-Tovar, F. Hernandez-Hernandez, and, R. Lopez-Martinez, (2008) Antifungal resistance: An emerging problem in Mexico. Gac. Med. Mex. 144, 23-26.
28. Martinez-Rossi, N. M., N. T. Peres, and, A. Rossi, (2008) Antifungal resistance mechanisms in dermatophytes. Mycopathologia 166, 369-383.
29. Sarifakioglu, E., D. Seckin, M. Demirbilek, and, F. Can, (2007) In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium. Clin. Exp. Dermatol. 32, 675-679.
30. Peres, N. T., P. R. Sanches, J. P. Falcao, H. C. Silveira, F. G. Paiao, F. C. Maranhao, D. E. Gras, F. Segato, R. A. Cazzaniga, M. Mazucato, J. R. Cursino-Santos, R. quino-Ferreira, A. Rossi, and, N. M. Martinez-Rossi, (2010) Transcriptional profiling reveals the expression of novel genes in response to various stimuli in the human dermatophyte Trichophyton rubrum. BMC Microbiol. 10, 39.
31. Mukherjee, P. K., S. D. Leidich, N. Isham, I. Leitner, N. S. Ryder, and, M. A. Ghannoum, (2003) Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrob. Agents Chemother. 47, 82-86.
32. Ramos-E-Silva, M., C. M. Lima, R. C. Schechtman, B. M. Trope, and, S. Carneiro, (2010) Superficial mycoses in immunodepressed patients (AIDS). Clin. Dermatol. 28, 217-225.
33. Gupta, A. K., and, S. Humke, (2000) The prevalence and management of onychomycosis in diabetic patients. Eur. J. Dermatol. 10, 379-384.
34. Khambaty, M. M., and, S. S. Hsu, (2010) Dermatology of the patient with HIV. Emerg. Med. Clin. North Am. 28, 355-68.
35. Ragas, X., M. Agut, and, S. Nonell, (2010) Singlet oxygen in Escherichia coli: New insights for antimicrobial photodynamic therapy. Free Radic. Biol. Med. 49, 770-776.
36. Hamblin, M. R., and, T. Hasan, (2004) Photodynamic therapy: A new antimicrobial approach to infectious disease? Photochem. Photobiol. Sci. 3, 436-450.
37. Maisch, T., R. M. Szeimies, N. Lehn, and, C. Abels, (2005) Antibacterial photodynamic therapy. A new treatment for superficial bacterial infections? Hautarzt 56, 1048-1055.
38. Hay, R., (2005) Literature review. Onychomycosis. J. Eur. Acad. Dermatol. Venereol. 19 (Suppl. 1), 1-7.
39. Emmons, C. W., (1934) Dermatophytes: Natural groupings based on the form of the spores and accessory organs. Arch. Derm. Syphilol. 30, 337-362.
40. Weitzman, I., and, R. C. Summerbell, (1995) The dermatophytes. Clin. Microbiol. Rev. 8, 240-259.
41. Mares, D., C. Romagnoli, G. Sacchetti, C. B. Vicentini, and, A. Bruni, (1999) Alterations in spore production in Trichophyton rubrum treated in vitro with 1-amino-6-methyl-4-phenylpyrazolo[3,4-d]-1,2,3-triazole. Mycoses 42, 549-554.
42. Odom, R., (1988) Dermatologic manifestations of AIDS. J. Am. Podiatr. Med. Assoc. 78, 127-129.
43. Wagner, D. K., and, P. G. Sohnle, (1995) Cutaneous defenses against dermatophytes and yeasts. Clin. Microbiol. Rev. 8, 317-335.
44. Svejgaard, E. L., (1995) Epidemiology of dermatophytes in Europe. Int. J. Dermatol. 34, 525-528.
45. Bang, H., (1910) Sur une trichophytie cutanée à grands cercles, causée par un dermatophyte nouveau (Trichophyton purpureum Bang). Ann. Dermatol. Syphiligr. 1, 225-238.
46. English, M. P., (1957) Trichophyton rubrum infection in families. Br. Med. J. 1, 744-746.
47. Moreno-Gimenez, J. C., (1991) Infections by Trichophyton rubrum. J. Am. Acad. Dermatol. 24, 323-324.
48. Seebacher, C., J. P. Bouchara, and, B. Mignon, (2008) Updates on the epidemiology of dermatophyte infections. Mycopathologia 166, 335-352.
49. Baran, R., and, A. Kaoukhov, (2005) Topical antifungal drugs for the treatment of onychomycosis: An overview of current strategies for monotherapy and combination therapy. J. Eur. Acad. Dermatol. Venereol. 19, 21-29.
50. Rippon, J. W., (1988) The pathogenic fungi and the pathogenic actinomycetes. In Medical Mycology (Edited by W.B. Saunders Co.), pp. 110-115. Philadelphia.
51. Shah, V. K., and, S. G. Knight, (1968) Chemical composition of hyphal walls of dermatophytes. Arch. Biochem. Biophys. 127, 229-234.
52. Gupta, A. K., and, E. A. Cooper, (2008) Update in antifungal therapy of dermatophytosis. Mycopathologia 166, 353-367.
53. Grappel, S. F., C. T. Bishop, and, F. Blank, (1974) Immunology of dermatophytes and dermatophytosis. Bacteriol. Rev. 38, 222-250.
54. San Blas, G., (1982) The cell wall of fungal human pathogens: Its possible role in host-parasite relationships. Mycopathologia 79, 159-184.
55. Deacon, J. W., (2006) The moulds of man. In Fungal Biology, pp. 322-338. Blackwell Publishing Ltd, Malden, MA, USA.
56. Kitajma, Y., (2000) Structural and biochemical characteristics of pathogenic fungus: Cell walls, lipids and dimorphism, and action modes of antifungal agents. Nippon Ishinkin Gakkai Zasshi 41, 211-217.
57. Hay, R. J., (2006) How do dermatophytes survive in the epidermis? Curr. Opin. Infect. Dis. 19, 125-126.
58. Zurita, J., and, R. J. Hay, (1987) Adherence of dermatophyte microconidia and arthroconidia to human keratinocytes in vitro. J. Invest. Dermatol. 89, 529-534.
59. Apodaca, G., and, J. H. McKerrow, (1989) Regulation of Trichophyton rubrum proteolytic activity. Infect. Immun. 57, 3081-3090.
60. Brasch, J., and, M. Zaldua, (1994) Enzyme patterns of dermatophytes. Mycoses 37, 11-16.
61. Maranhao, F. C., F. G. Paiao, and, N. M. Martinez-Rossi, (2007) Isolation of transcripts over-expressed in human pathogen Trichophyton rubrum during growth in keratin. Microb. Pathog. 43, 166-172.
62. Brasch, J., (2010) Pathogenesis of tinea. J. Dtsch. Dermatol. Ges. 8 (10), 780-786.
63. Gupta, A. K., T. R. Einarson, R. C. Summerbell, and, N. H. Shear, (1998) An overview of topical antifungal therapy in dermatomycoses. A North American perspective. Drugs 55, 645-674.
64. Evans, E. G., (2001) The rationale for combination therapy. Br. J. Dermatol. 145 (Suppl. 60), 9-13.
65. Kyle, A. A., and, M. V. Dahl, (2004) Topical therapy for fungal infections. Am. J. Clin. Dermatol. 5, 443-451.
66. Santos, D. A., and, J. S. Hamdan, (2006) In vitro antifungal oral drug and drug-combination activity against onychomycosis causative dermatophytes. Med. Mycol. 44, 357-362.
67. Claveau, J., R. B. Vender, and, A. K. Gupta, (2006) Multitherapy approach to onychomycosis therapy. J. Cutan. Med. Surg. 10 (Suppl. 2), S44-S47.
68. Hay, R. J., (1993) Therapy. In Fungi and Skin disease, pp. 72-74. Wolfe Publishing, London.
69. Borgers, M., H. Degreef, and, G. Cauwenbergh, (2005) Fungal infections of the skin: Infection process and antimycotic therapy. Curr. Drug Targets 6, 849-862.
70. Aratari, E., G. Virno, and, A. Persi, (1983) Cyclopiroxolamine (HOE 296), new antimycotic substance, in superficial mycosis. G. Ital. Dermatol. Venereol. 118, I-VI.
71. Vera, J. R., and, L. A. Cervera, (2001) Advantages and disadvantages of topical antifungal agents. Rev. Esp. Quimioter. 14, 232-237.
72. Tappeiner, H.v., and, A. Jodlbauer, (1907) Die sensibilisierende Wirkung fluorescierender substanzen. Gesammelte Untersuchungen über die photodynamische Erscheinung. F.C.W.Vogel, Leipzig, Germany.
73. Ravindra, K., R. K. Pandey, and, G. Zheng, (2000) Porphyrins and photosensitizers. In The Porphyrin Handbook, Vol. 6 (Edited by, K. M. Kadish, K. Smith, and, R. Guilard,), pp. 157-161. Academic Press, San Diego, CA, USA.
74. Lee, P. C., and, M. A. Rodgers, (1987) Laser flash photokinetic studies of rose bengal sensitized photodynamic interactions of nucleotides and DNA. Photochem. Photobiol. 45, 79-86.
75. Potapenko, A. Y., (1991) Mechanisms of photodynamic effects of furocoumarins. J. Photochem. Photobiol. B 9, 1-33.
76. Tripathy, B. C., A. Mohapatra, and, I. Gupta, (2007) Impairment of the photosynthetic apparatus by oxidative stress induced by photo sensitization reaction of protoporphyrin IX. Biochim. Biophys. Acta-Bioenerg. 1776, 860-868.
77. Ricchelli, F., (1995) Photophysical properties of porphyrins in biological membranes. J. Photochem. Photobiol. B 29, 109-118.
78. Bertoloni, G., F. Zambotto, L. Conventi, E. Reddi, and, G. Jori, (1987) Role of specific cellular targets in the hematoporphyrin-sensitized photoinactivation of microbial cells. Photochem. Photobiol. 46, 695-698.
79. Demidova, T. N., and, M. R. Hamblin, (2004) Photodynamic therapy targeted to pathogens. Int. J. Immunopathol. Pharmacol. 17, 245-254.
80. Lambrechts, S. A., M. C. Aalders, D. H. Langeveld-Klerks, Y. Khayali, and, J. W. Lagerberg, (2004) Effect of monovalent and divalent cations on the photoinactivation of bacteria with meso-substituted cationic porphyrins. Photochem. Photobiol. 79, 297-302.
81. Jori, G., C. Fabris, M. Soncin, S. Ferro, O. Coppellotti, D. Dei, L. Fantetti, G. Chiti, and, G. Roncucci, (2006) Photodynamic therapy in the treatment of microbial infections: Basic principles and perspective applications. Lasers Surg. Med. 38, 468-481.
82. Merchat, M., J. D. Spikes, G. Bertoloni, and, G. Jori, (1996) Studies on the mechanism of bacteria photosensitization by meso-substituted cationic porphyrins. J. Photochem. Photobiol. B 35, 149-157. (Pubitemid 26383615)
83. Merchat, M., G. Bertolini, P. Giacomini, A. Villanueva, and, G. Jori, (1996) Meso-substituted cationic porphyrins as efficient photosensitizers of gram-positive and gram-negative bacteria. J. Photochem. Photobiol. B 32, 153-157. (Pubitemid 26127371)
84. Peng, Q., K. Berg, J. Moan, M. Kongshaug, and, J. M. Nesland, (1997) 5-Aminolevulinic acid-based photodynamic therapy: Principles and experimental research. Photochem. Photobiol. 65, 235-251. (Pubitemid 27158805)
85. Webber, J., D. Kessel, and, D. Fromm, (1997) Side effects and photosensitization of human tissues after aminolevulinic acid. J. Surg. Res. 68, 31-37.
86. Taylor, E. L., and, S. B. Brown, (2002) The advantages of aminolevulinic acid photodynamic therapy in dermatology. J. Dermatolog. Treat. 13 (Suppl. 1), S3-11.
87. Lee, J. W., B. J. Kim, and, M. N. Kim, (2010) Photodynamic therapy: New treatment for recalcitrant Malassezia folliculitis. Lasers Surg. Med. 42, 192-196.
88. Romagnoli, C., D. Mares, G. Sacchetti, and, A. Bruni, (1998) The photodynamic effect of 5-(4-hydroxy-1-butinyl)-2,2-bithienyl on dermatophytes. Mycol. Res. 102, 1519-1524.
89. Donnelly, R. F., P. A. McCarron, J. M. Lightowler, and, A. D. Woolfson, (2005) Bioadhesive patch-based delivery of 5-aminolevulinic acid to the nail for photodynamic therapy of onychomycosis. J. Control Release 103, 381-392.
90. Horio, T., (1981) Evaluation of drug phototoxicity by photosensitization of Trichophyton mentagrophytes. Br. J. Dermatol. 105, 365-370.
91. Ouf, S. A., M. H. bdel-Kader, H. A. Shokeir, and, A. A. El-Adly, (2003) Study of solar photosensitization processes on dermatophytic fungi. Acta Microbiol. Pol. 52, 65-79.
92. Smijs, T. G., and, H. J. Schuitmaker, (2003) Photodynamic inactivation of the dermatophyte Trichophyton rubrum. Photochem. Photobiol. 77, 556-560.
93. Smijs, T. G., R. N. van der Haas, J. Lugtenburg, Y. Liu, R. L. de Jong, and, H. J. Schuitmaker, (2004) Photodynamic treatment of the dermatophyte Trichophyton rubrum and its microconidia with porphyrin photosensitizers. Photochem. Photobiol. 80, 197-202.
94. Pavel, S., (2006) Light therapy (with UVA-1) for SLE patients: Is it a good or bad idea? Rheumatology (Oxford) 45, 653-655.
95. Smijs, T. G., s. Pavel, M. Talebi, and, J. A. Bouwstra, (2009) Preclinical studies with 5,10,15-Tris(4-methylpyridinium)-20-phenyl-[21H,23H]- porphine trichloride for the photodynamic treatment of superficial mycoses caused by Trichophyton rubrum. Photochem. Photobiol. 85, 733-739.
96. Smijs, T. G., A. A. Mulder, S. Pavel, J. J. Onderwater, H. K. Koerten, and, J. A. Bouwstra, (2008) Morphological changes of the dermatophyte Trichophyton rubrum after photodynamic treatment: A scanning electron microscopy study. Med. Mycol. 46, 315-325.
97. Smijs, T. G., J. A. Bouwstra, H. J. Schuitmaker, M. Talebi, and, S. Pavel, (2007) A novel ex vivo skin model to study the susceptibility of the dermatophyte Trichophyton rubrum to photodynamic treatment in different growth phases. J. Antimicrob. Chemother. 59, 433-440.
98. Smijs, T. G., J. A. Bouwstra, M. Talebi, and, s. Pavel, (2007) Investigation of conditions involved in the susceptibility of the dermatophyte Trichophyton rubrum to photodynamic treatment. J. Antimicrob. Chemother. 60, 750-759. (Pubitemid 47434252)
99. Aljabre, S. H., M. D. Richardson, E. M. Scott, A. Rashid, and, G. S. Shankland, (1993) Adherence of arthroconidia and germlings of anthropophilic and zoophilic varieties of Trichophyton mentagrophytes to human corneocytes as an early event in the pathogenesis of dermatophytosis. Clin. Exp. Dermatol. 18, 231-235.
100. Piraccini, B. M., G. Rech, and, A. Tosti, (2008) Photodynamic therapy of onychomycosis caused by Trichophyton rubrum. J. Am. Acad. Dermatol. 59, S75-S76.
101. Watanabe, D., C. Kawamura, Y. Masuda, Y. Akita, Y. Tamada, and, Y. Matsumoto, (2008) Successful treatment of toenail onychomycosis with photodynamic therapy. Arch. Dermatol. 144, 19-21.
102. Sotiriou, E., T. Koussidou, A. Patsatsi, Z. Apalla, and, D. Ioannides, (2009) 5-Aminolevulinic acid-photodynamic treatment for dermatophytic tinea pedis of interdigital type: A small clinical study. J. Eur. Acad. Dermatol. Venereol. 23, 203-204.
103. Sotiriou, E., T. Koussidou-Eremonti, G. Chaidemenos, Z. Apalla, and, D. Ioannides, (2010) Photodynamic therapy for distal and lateral subungual toenail onychomycosis caused by Trichophyton rubrum: Preliminary results of a single-centre open trial. Acta Derm. Venereol. 90, 216-217.
104. Sotiriou, E., D. Panagiotidou, and, D. Ioannides, (2009) 5-Aminolevulininic acid photodynamic therapy treatment for tinea cruris caused by Trichophyton rubrum: Report of 10 cases. J. Eur. Acad. Dermatol. Venereol. 23, 341-342.
105. Polderman, M. C., C. S. le, T. W. Huizinga, and, S. Pavel, (2004) Efficacy of UVA-1 cold light as an adjuvant therapy for systemic lupus erythematosus. Rheumatology (Oxford) 43, 1402-1404.
106. Polderman, M. C., M. Wintzen, C. S. le, and, S. Pavel, (2005) UVA-1 cold light therapy in the treatment of atopic dermatitis: 61 patients treated in the Leiden University Medical Center. Photodermatol. Photoimmunol. Photomed. 21, 93-96.
107. Polderman, M. C., M. Wintzen, R. L. van Leeuwen, W. S. de, and, S. Pavel, (2004) Ultraviolet A1 in the treatment of generalized lichen planus: A report of 4 cases. J. Am. Acad. Dermatol. 50, 646-647.
108. Lavker, R., and, K. Kaidbey, (1997) The spectral dependence for UVA-induced cumulative damage in human skin. J. Invest. Dermatol. 108, 17-21.
109. Landsman, A. S., A. H. Robbins, P. F. Angelini, C. C. Wu, J. Cook, M. Oster, and, E. S. Bornstein, (2010) Treatment of mild, moderate, and severe onychomycosis using 870- and 930-nm light exposure. J. Am. Podiatr. Med. Assoc. 100, 166-177.
110. Dai, T., G. P. Tegos, G. Rolz-Cruz, W. E. Cumbie, and, M. R. Hamblin, (2008) Ultraviolet C inactivation of dermatophytes: Implications for treatment of onychomycosis. Br. J. Dermatol. 158, 1239-1246.
111. Zeina, B., J. Greenman, D. Corry, and, W. M. Purcell, (2002) Cytotoxic effects of antimicrobial photodynamic therapy on keratinocytes in vitro. Br. J. Dermatol. 146, 568-573.
112. Gupta, A. K., I. Ahmad, M. Porretta, and, R. C. Summerbell, (2003) Arthroconidial formation in Trichophyton raubitschekii. Mycoses 46, 322-328.